Pancreatic deletion of insulin receptor substrate 2 reduces beta and alpha cell mass and impairs glucose homeostasis in mice

By Cantley J.   Choudhury A.   Asare-Anane H.   Selman C.   Lingard S.   Heffron H.   Herrera P.   Persaud S.   Withers D.  

Diabetologia, Vol. 50, Iss. 6, 2007-06 ,pp. : 1248-1256

Springer Publishing Company

Access to resources Recommend Favorite

Olmesartan and telmisartan comparably preserve pancreatic beta-cell mass with reduction of oxidative stress in db/db mice

By Shigihara Nayumi   Uchida Toyoyoshi   Yorifuji Takashi   Toyofuku Yukiko   Tamaki Motoyuki   Fujitani Yoshio   Watada Hirotaka  

Diabetology International, Vol. 5, Iss. 1, 2014-03 ,pp. : 62-68

Springer Publishing Company

Access to resources Recommend Favorite

The angiotensin II type I receptor blocker olmesartan inhibits the growth of pancreatic cancer by targeting stellate cell activities in mice

By Masamune Atsushi   Hamada Shin   Kikuta Kazuhiro   Takikawa Tetsuya   Miura Shin   Nakano Eriko   Shimosegawa Tooru  

Scandinavian Journal of Gastroenterology, Vol. 48, Iss. 5, 2013-05 ,pp. : 602-609

Informa Healthcare

Access to resources Recommend Favorite

Cell lineage dynamics in the process leading to intestinal metaplasia

By Sakamoto Hirotsugu  

Journal of Gastroenterology, Vol. 46, Iss. 5, 2011-05 ,pp. : 620-628

Springer Publishing Company

Access to resources Recommend Favorite

Pancreatic Squamous Cell Carcinoma

By  

Case Reports in Gastroenterology, Vol. 11, Iss. 1, 2017-04 ,pp. : 219-224

Karger

Access to resources Recommend Favorite